Cargando…
Carbonic Anhydrase Inhibitors: A New Dawn for the Treatment of Obstructive Sleep Apnea
Autores principales: | Chen, Riken, Liao, Huizhao, Chen, Xiaojuan, Wang, Chaoyu, Wu, Huiyu, Zheng, Zhenzhen, Lu, Jianmin, Lin, Junyan, Huang, Zijie, Lin, Jiangpeng, Zhong, Nanshan, Zhang, Nuofu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802001/ https://www.ncbi.nlm.nih.gov/pubmed/35820074 http://dx.doi.org/10.1164/rccm.202206-1209LE |
Ejemplares similares
-
Mild Intermittent Hypoxia: A New Treatment Approach for Patients with Obstructive Sleep Apnea and Hypertension
por: Chen, Riken, et al.
Publicado: (2022) -
Relationship between obstructive sleep apnea-hypopnea syndrome and osteoporosis adults: A systematic review and meta-analysis
por: Wang, Chaoyu, et al.
Publicado: (2022) -
Association of Obstructive Sleep Apnea-Hypopnea Syndrome with hearing loss: A systematic review and meta-analysis
por: Wang, Chaoyu, et al.
Publicado: (2022) -
Application value of joint STOP-Bang questionnaire and Epworth Sleepiness Scale in screening for obstructive sleep apnea
por: Zheng, Zhenzhen, et al.
Publicado: (2022) -
Comparison of six assessment tools to screen for obstructive sleep apnea in patients with hypertension
por: Zheng, Zhenzhen, et al.
Publicado: (2021)